Format

Send to

Choose Destination
See comment in PubMed Commons below
Int J Mol Sci. 2012;13(2):1933-50. doi: 10.3390/ijms13021933. Epub 2012 Feb 10.

Glucose-modulated mitochondria adaptation in tumor cells: a focus on ATP synthase and inhibitor Factor 1.

Author information

1
Department of Medical and Biological Sciences, University of Udine, p.le Kolbe 4, 33100 Udine, Italy; E-Mails: rossana.domenis@uniud.it (R.D.); elena.bisetto@uniud.it (E.B.); davide.rossi@uniud.it (D.R.); marina.comelli@uniud.it (M.C.).

Abstract

Warburg's hypothesis has been challenged by a number of studies showing that oxidative phosphorylation is repressed in some tumors, rather than being inactive per se. Thus, treatments able to shift energy metabolism by activating mitochondrial pathways have been suggested as an intriguing basis for the optimization of antitumor strategies. In this study, HepG2 hepatocarcinoma cells were cultivated with different metabolic substrates under conditions mimicking "positive" (activation/biogenesis) or "negative" (silencing) mitochondrial adaptation. In addition to the expected up-regulation of mitochondrial biogenesis, glucose deprivation caused an increase in phosphorylating respiration and a rise in the expression levels of the ATP synthase β subunit and Inhibitor Factor 1 (IF1). Hyperglycemia, on the other hand, led to a markedly decreased level of the transcriptional coactivator PGC-α suggesting down-regulation of mitochondrial biogenesis, although no change in mitochondrial mass and no impairment of phosphorylating respiration were observed. Moreover, a reduction in mitochondrial networking and in ATP synthase dimer stability was produced. No effect on β-ATP synthase expression was elicited. Notably, hyperglycemia caused an increase in IF1 expression levels, but it did not alter the amount of IF1 associated with ATP synthase. These results point to a new role of IF1 in relation to high glucose utilization by tumor cells, in addition to its well known effect upon mitochondrial ATP synthase regulation.

KEYWORDS:

ATP synthase; HepG2; aglycemia; hyperglycemia; inhibitory factor 1; metabolic adaptation; mitochondria; oxidative phosphorylation; tumor bioenergetics

PMID:
22408432
PMCID:
PMC3292001
DOI:
10.3390/ijms13021933
[Indexed for MEDLINE]
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Multidisciplinary Digital Publishing Institute (MDPI) Icon for PubMed Central
    Loading ...
    Support Center